Children with diabetes who inhaled their mealtime doses of insulin did just as well as those who injected insulin under the ...

Children with diabetes who inhaled their mealtime doses of insulin did just as well as those who injected insulin under the ...

A study finds that inhaled insulin is as effective as traditional injections for children with type 1 diabetes during ...

Inhaled insulin is an “important alternative” to injected rapid-acting analog insulin for children and teens with diabetes, ...

New study results demonstrated the safety and efficacy of the MannKind Afrezza inhaled insulin offering for children with ...

MannKind Corporation (NASDAQ:MNKD) is one of the 11 Best US Stocks to Invest in Under $5. MannKind Corporation (NASDAQ:MNKD) ...

An earlier inhaled insulin, Pfizer's Exubera, which was withdrawn from the market after disappointing sales, may cast a pall on the newcomer's prospects (Nat. Biotechnol. 25, 1331–1332, 2007).

WASHINGTON -- The first inhalable version of insulin won federal approval Friday, giving millions of adult diabetics an alternative to some of the injections they now endure. The Food and Drug ...

“Inhaled insulin can quickly get to the carbohydrates that are in the bloodstream, get them into the cells and out of the ...

Exubera, the inhalable insulin finally approved in both the US and Europe in late January, has been touted by many industry analysts as a drug with a $2–3 billion sales potential.